NanoVibronix Gross Profit 2011-2026 | NAOV

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:

Raw materials and supplies

Wages of production personnel

Depreciation of equipment

Transportation and warehousing costs (if directly related to production)

Importance for business:

Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales.
Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit.
Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry.
Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.

Reasons for a decline in gross profit:

Increase in raw material and supply costs
Rising production expenses
Price reductions due to competition
Decrease in sales volume
Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit NanoVibronix

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.51 M	1.54 M	167 K	770 K	214	281 K	160 K	151 K	141 K	98 K	110 K	120 K	116 K	65 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.54 M	214	373 K

Quarterly Gross Profit NanoVibronix

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
189 K	-35 K	369 K	-	133 K	428 K	664 K	-	349 K	216 K	235 K	-	80 K	281 K	106 K	-	228 K	208 K	77 K	-	99 K	38 K	51 K	-	47 K	207 K	53 K	-	8 K	77 K	55 K	-	43 K	34 K	36 K	-	34 K	40 K	30 K	-	30 K	24 K	19 K	-	-10 K	39 K	-40 K	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
664 K	-40 K	123 K

Gross Profit of other stocks in the Medical devices industry

Issuer	Gross Profit	Price	% 24h	Market Cap	Country
Aethlon Medical AEMD	1.36 M	$ 2.11	8.21 %	$ 3.29 M	USA
AdaptHealth Corp. AHCO	89.3 M	$ 10.42	-1.65 %	$ 1.41 B	USA
Allied Healthcare Products AHPI	443 K	-	3.58 %	$ 2.21 M	USA
GenMark Diagnostics, Inc. GNMK	67.9 M	-	-	$ 1.77 B	USA
Acutus Medical AFIB	-3.14 M	-	-26.83 %	$ 2.62 M	USA
Alphatec Holdings ATEC	532 M	$ 12.6	2.61 %	$ 1.89 B	USA
Butterfly Network BFLY	48.8 M	$ 3.91	2.62 %	$ 828 M	USA
Obalon Therapeutics, Inc. OBLN	584 K	-	-5.86 %	$ 30.6 M	USA
Cognyte Software Ltd. CGNT	247 M	$ 8.38	-0.24 %	$ 602 M	Israel
Aziyo Biologics AZYO	6.6 M	-	1.37 %	$ 20.5 M	USA
Avinger AVGR	2 M	-	-20.74 %	$ 369 K	USA
BIOLASE BIOL	16.7 M	-	-13.19 %	$ 166 K	USA
Boston Scientific Corporation BSX	13.9 B	$ 69.79	0.95 %	$ 103 B	USA
Conformis CFMS	23.2 M	-	-	$ 16.4 M	USA
EDAP TMS S.A. EDAP	26.6 M	$ 3.96	1.02 %	$ 148 M	France
CONMED Corporation CNMD	750 M	$ 37.41	0.35 %	$ 1.16 B	USA
Apollo Endosurgery APEN	42.4 M	-	-	$ 475 M	USA
Cytosorbents Corporation CTSO	25.1 M	$ 0.65	-8.13 %	$ 35.4 M	USA
Cutera CUTR	-12.7 M	-	-10.19 %	$ 1.99 M	USA
CryoLife, Inc. CRY	168 M	-	-4.14 %	$ 702 M	USA
Dynatronics Corporation DYNT	6.01 M	-	14.99 %	$ 929 K	USA
ClearPoint Neuro CLPT	19.1 M	$ 11.03	2.22 %	$ 298 M	USA
Establishment Labs Holdings ESTA	146 M	$ 63.48	0.21 %	$ 1.88 B	Costa-rica
Axonics Modulation Technologies AXNX	198 M	-	-	$ 3.31 B	USA
Hancock Jaffe Laboratories, Inc. HJLI	4.25 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	28.7 M	-	0.03 %	$ 1.58 B	Israel
Misonix, Inc. MSON	43.7 M	-	-	$ 462 M	USA
Neovasc NVCN	1.99 M	-	-	$ 111 M	Canada
FONAR Corporation FONR	42.4 M	$ 18.42	0.22 %	$ 121 M	USA
InMode Ltd. INMD	291 M	$ 13.43	-0.81 %	$ 868 M	Israel
GBS GBS	1.25 M	-	-0.57 %	$ 7.12 M	USA
Intersect ENT, Inc. XENT	50.2 M	-	-	$ 955 M	USA
Abbott Laboratories ABT	18.7 B	$ 109.95	1.8 %	$ 191 B	USA
Delcath Systems DCTH	73.4 M	$ 9.81	3.81 %	$ 351 M	USA
Bio-Rad Laboratories BIO	342 M	$ 261.24	-0.59 %	$ 7.37 B	USA
Helius Medical Technologies HSDT	61 K	$ 2.19	3.79 %	$ 1.33 M	USA
Integra LifeSciences Holdings Corporation IART	953 M	$ 9.01	-2.49 %	$ 694 M	USA
AxoGen AXGN	167 M	$ 32.84	1.55 %	$ 1.51 B	USA
Align Technology ALGN	2.8 B	$ 169.45	3.18 %	$ 12.7 B	USA
Bruker Corporation BRKR	1.65 B	$ 32.76	-2.93 %	$ 4.88 K	USA
IRIDEX Corporation IRIX	21.8 M	$ 1.33	2.31 %	$ 21.5 M	USA
BioSig Technologies BSGM	229 K	-	37.08 %	$ 85.7 M	USA
Apyx Medical Corporation APYX	33 M	$ 3.67	1.1 %	$ 151 M	USA
OrthoPediatrics Corp. KIDS	173 M	$ 17.11	-1.16 %	$ 401 M	USA
Integer Holdings Corporation ITGR	500 M	$ 84.12	1.34 %	$ 2.92 B	USA
Invacare Corporation IVC	48.3 M	-	-	$ 24.7 M	USA
Second Sight Medical Products EYES	500 K	-	-0.97 %	$ 54.4 M	USA